Deciphering the nanomaterial uptake in a bystander manner invoked by co-administration of functionalized nanoparticles
Deciphering the nanomaterial uptake in a bystander manner invoked by co-administration of functionalized nanoparticles
批准号:
10170384
负责人:
Hongbo Pang
金额:
$30.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-01 至 2023-05-31
关键词:
Amino AcidsBindingCaliberCell Surface ReceptorsCell membraneCell physiologyCell surfaceCellsCellular biologyComplexCoupledCysteineDiagnosisDrug Delivery SystemsEndocytosisEnvironmentGene DeliveryGeneticGenetic ScreeningGenetic TranscriptionGoalsHeparan Sulfate ProteoglycanHeparitin SulfateLigandsLightLinkLiquid substanceMediatingMembraneMetabolicMetabolismMethodsMolecular ProfilingNanotechnologyNutrientPathway interactionsPeptidesPlayProcessPropertyRNA interference screenRegulationResearchRoleSignal TransductionSiteSulfateTissuesVacuoleValidationVesicleextracellulargenome-widehuman diseasein vivoinsightnanomaterialsnanoparticlenanoparticle deliverynanoscalenovelparticlereceptorsynergismuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
One important yet understudied aspect in nanomaterial applications is the cell biology of nanomaterial
transport into cells and through tissues. To overcome the cell membranes and reach their sites of action
within, nanoparticles (NPs) are often complexed with cell-penetrating ligands. Such ligands include peptides
like TAT (Trans-Activating Transcription). These ligands engage with cell surface receptors to invoke
endocytic processes for NP uptake. However, the impact of these functionalized NPs and the resulting
endocytic process on the cellular uptake of other NPs remains unknown. In this proposal, I aim to tackle this
problem by studying TAT-coupled NPs (TAT-NP).
By tracing NPs coated with several cell-penetrating peptides, including TAT, we previously discovered a
novel receptor-dependent macropinocytosis (MP) pathway for NP uptake. MP has relatively large endocytic
vacuoles (>200 nm in diameter) and thus can more readily engulf cargo as large as nanoparticles. Here, we
found that TAT-NPs, by invoke this MP pathway, can bring into cells bystander NPs that are unable to enter
the cells by themselves. This bystander uptake depends on TAT interaction with its receptor, heparan sulfate
(HS) proteoglycans, and occurs through the HS-dependent MP pathway. We further showed that it is only
active for NP-type bystander cargo, and its activity is greatly stimulated by Cysteine (Cys) outside the cells.
Here, we aim to dissect out this bystander uptake process. In the Aim 1, we will determine the prerequisites
for initiating the bystander uptake. In the Aim 2 and 3, we will utilize genetic screening and other methods to
determine the factors that mediate this bystander uptake, and define its properties of cargo selectivity and
Cys regulation. In the Aim 4, we will explore the potential use in biomedical applications. My proposed
studies hold great potential for unveiling important cellular machineries for nanomaterial transport, boosting
the efficiency of intracellular delivery, and opening up a new avenue to study cell biology, metabolism and
nanomaterial delivery.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deciphering the nanomaterial uptake in a bystander manner invoked by co-administration of functionalized nanoparticles
-
批准号:10005420
-
项目类别:
-
资助金额:$30.42万
-
财政年份:2019
-
负责人:Hongbo Pang
-
依托单位:
Deciphering the nanomaterial uptake in a bystander manner invoked by co-administration of functionalized nanoparticles
-
批准号:10403647
-
项目类别:
-
资助金额:$30.42万
-
财政年份:2019
-
负责人:Hongbo Pang
-
依托单位:
Improving the in Vivo Delivery and Antitumor Efficacy of Antisense Drugs
-
批准号:9761470
-
项目类别:
-
资助金额:$33.21万
-
财政年份:2017
-
负责人:Hongbo Pang
-
依托单位:
Improving the in Vivo Delivery and Antitumor Efficacy of Antisense Drugs
-
批准号:10219981
-
项目类别:
-
资助金额:$34.02万
-
财政年份:2017
-
负责人:Hongbo Pang
-
依托单位:
Improving the in vivo delivery and antitumor efficacy of antisense drugs
-
批准号:9289598
-
项目类别:
-
资助金额:$11.06万
-
财政年份:2017
-
负责人:Hongbo Pang
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: